AH
BMY icon

Andreas Halvorsen’s Bristol-Myers Squibb BMY Stock Holding History

Andreas Halvorsen’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,815,619
Closed -$113M – 97
2021
Q4 		$113M Sell
1,815,619
-5,207,645
-74% -$305M 0.33% 70
2021
Q3 		$416M Sell
7,023,264
-4,294,488
-38% -$283M 1.14% 30
2021
Q2 		$756M Buy
11,317,752
+6,122,279
+118% +$399M 2.29% 14
2021
Q1 		$328M Buy
5,195,473
+2,688,680
+107% +$167M 0.98% 35
2020
Q4 		$155M Sell
2,506,793
-682,471
-21% -$42M 0.43% 59
2020
Q3 		$192M Buy
+3,189,264
New +$192M 0.69% 43

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Andreas Halvorsen's BMY Position: Q1 2022 in Review

Andreas Halvorsen sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 1,815,619 shares — an estimated $113M sold.

Andreas Halvorsen first reported a position in BMY in Q3 2020 and held it in 6 quarters. The position peaked at $756M in Q2 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • Andreas Halvorsen reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
  • Andreas Halvorsen sold 1,815,619 Bristol-Myers Squibb shares in Q1 2022, an estimated $113M.
  • Andreas Halvorsen first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 6 quarters.
  • Andreas Halvorsen's Bristol-Myers Squibb position peaked at $756M in Q2 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Viking Global Investors's 13F filing for Q1 2022, filed 16 May 2022.